CONMED CORPORATION Lease, Cost
CONMED CORPORATION (CNMD) reported Lease, Cost of $11.44 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-17
- CONMED CORPORATION lease, cost for the quarter ending 2019-12-31 was $1.93M.
- CONMED CORPORATION lease, cost for the quarter ending 2019-09-30 was $2.33M.
- CONMED CORPORATION lease, cost for the quarter ending 2019-06-30 was $2.05M.
- CONMED CORPORATION lease, cost for the quarter ending 2019-03-31 was $2.06M.
- CONMED CORPORATION lease, cost for fiscal 2025 was $11.44M, a 14.17% increase from fiscal 2024.
- CONMED CORPORATION lease, cost for fiscal 2024 was $10.02M, a 17.65% increase from fiscal 2023.
- CONMED CORPORATION lease, cost for fiscal 2023 was $8.52M, a 5.17% increase from fiscal 2022.
- CONMED CORPORATION lease, cost for fiscal 2022 was $8.10M, a 0.50% decline from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $11.44M 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $10.02M 10-K · filed 2026-02-17 | |||
| 2023-12-31 | $8.52M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $8.10M 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $8.14M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $7.64M 10-K · filed 2023-02-21 | |||
| 2019-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.26M derived: sum of 2 quarters · filed 2022-02-22 | $6.30M derived: sum of 3 quarters · filed 2022-02-22 | $8.36M 10-K · filed 2022-02-22 |
| 2019-09-30 | $2.33M 10-Q · filed 2019-10-31 | $4.38M derived: sum of 2 quarters · filed 2019-10-31 | $6.43M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $2.05M 10-Q · filed 2019-08-01 | $4.09M 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $2.06M 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |